الاتحاد الأوروبي - الدانماركية - EMA (European Medicines Agency)

alnylam netherlands b.v. - lumasiran sodium - hyperoxaluria, primary - andre alimentary tract and metabolism produkter, - treatment of primary hyperoxaluria type 1 (ph1) in all age groups.

الاتحاد الأوروبي - الدانماركية - EMA (European Medicines Agency)

viiv healthcare b.v. - cabotegavir sodium, cabotegravir - hiv infektioner - antivirale midler til systemisk anvendelse - vocabria tablets are indicated in combination with rilpivirine tablets for the short-term treatment of human immunodeficiency virus type 1 (hiv-1) infection in adults who are virologically suppressed (hiv-1 rna.

الاتحاد الأوروبي - الدانماركية - EMA (European Medicines Agency)

mylan ireland limited - sugammadex sodium - neuromuskulær blokade - alle andre terapeutiske produkter - reversal of neuromuscular blockade induced by   rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.

الاتحاد الأوروبي - الدانماركية - EMA (European Medicines Agency)

fresenius kabi deutschland gmbh - sugammadex sodium - neuromuskulær blokade - alle andre terapeutiske produkter - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.

الاتحاد الأوروبي - الدانماركية - EMA (European Medicines Agency)

gilead sciences ireland unlimited company - lenacapavir sodium - hiv infektioner - antivirale midler til systemisk anvendelse - sunlenca injection, in combination with other antiretroviral(s), is indicated for the treatment of adults with multidrug resistant hiv 1 infection for whom it is otherwise not possible to construct a suppressive anti viral regimen (see sections 4. 2 og 5. sunlenca tablet, in combination with other antiretroviral(s), is indicated for the treatment of adults with multidrug resistant hiv 1 infection for whom it is otherwise not possible to construct a suppressive anti viral regimen, for oral loading prior to administration of long-acting lenacapavir injection (see sections 4. 2 og 5.

الاتحاد الأوروبي - الدانماركية - EMA (European Medicines Agency)

alnylam netherlands b.v. - vutrisiran sodium - amyloid neuropathies, familial - andre narkotika stoffer - treatment of hereditary transthyretin-mediated amyloidosis (hattr amyloidosis) in adult patients with stage 1 or stage 2 polyneuropathy.

الاتحاد الأوروبي - الدانماركية - EMA (European Medicines Agency)

aop orphan pharmaceuticals gmbh - sugammadex sodium - neuromuskulær blokade - alle andre terapeutiske produkter - tilbagevendelse af neuromuskulær blokade induceret af rocuronium eller vecuronium. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.

الاتحاد الأوروبي - الدانماركية - EMA (European Medicines Agency)

piramal critical care b.v. - sugammadex sodium - neuromuskulær blokade - sugammadex - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults.

الاتحاد الأوروبي - الدانماركية - EMA (European Medicines Agency)

extrovis eu ltd. - sugammadex sodium - neuromuskulær blokade - alle andre terapeutiske produkter - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.

الاتحاد الأوروبي - الدانماركية - EMA (European Medicines Agency)

eurocept international b. v. - natrium phenylbutyrate - carbamoyl-phosphat-syntase jeg mangelsygdom - forskellige alimentary tract and metabolism produkter - behandling af kroniske forvaltning af urinstof-cyklus lidelser.